Condition: Hypertriglyceridemia · Severe Hypertriglyceridemia · Sponsor: Ionis Pharmaceuticals, Inc.
The main objective of this study is to evaluate the effect of ION775 on fasting triglyceride (TG) levels in participants with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (sHTG).
This description comes directly from the study's public registry record.
Ionis Pharmaceuticals, Inc. · 1-844-828-3770 · IonisION775-CS2@clinicaltrialmedia.com
Always discuss trial participation with your own doctor first.
| Ionis Investigative Site | Lincoln, California, United States | Recruiting |
| Ionis Investigative Site | Aurora, Colorado, United States | Recruiting |
| Ionis Investigative Site | Boca Raton, Florida, United States | Recruiting |
| Ionis Investigative Site | Miami, Florida, United States | Recruiting |
| Ionis Investigative Site | Miramar, Florida, United States | Recruiting |
| Ionis Investigative Site | Columbus, Georgia, United States | Recruiting |
| Ionis Investigative Site | Louisville, Kentucky, United States | Recruiting |
| Ionis Investigative Site | Flint, Michigan, United States | Recruiting |
| Ionis Investigative Site | Munroe Falls, Ohio, United States | Recruiting |
| Ionis Investigative Site | Little River, South Carolina, United States | Recruiting |
| Ionis Investigative Site | Houston, Texas, United States | Recruiting |
| Ionis Investigative Site | Lampasas, Texas, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07604974